Literature DB >> 10517867

Membrane associated matrix metalloproteinases in metastasis.

S M Ellerbroek1, M S Stack.   

Abstract

Hematogenous metastasis is postulated to involve tumor cell-initiated degradation of basement membrane barriers and underlying connective tissue matrices. Matrix metalloproteinases (MMP) are zinc-dependent endopeptidases that have been implicated in the proteolytic events of tumor cell invasion. Research has revealed a class of membrane-anchored metalloproteinases (MT-MMPs) and has provided convincing evidence that these enzymes activate latent MMP-2 (72 kDa gelatinase A) on the cell surface. The activation of plasma membrane associated MMP is a potential mechanism for facilitation of cellular metastasis and requires consideration when addressing potential roles of MMPs in tumor progression. This review focuses on potential in vivo regulatory mechanisms of membrane-associated MMP activity in the context of tumor cell interaction with matrix macromolecules. BioEssays 1999;21:940-949. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517867     DOI: 10.1002/(SICI)1521-1878(199911)21:11<940::AID-BIES6>3.0.CO;2-J

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  40 in total

1.  An extracellular matrix-associated zinc metalloprotease is required for dilauroyl phosphatidylethanolamine chemotactic excitation in Myxococcus xanthus.

Authors:  Daniel B Kearns; Pamela J Bonner; Daniel R Smith; Lawrence J Shimkets
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

2.  Sustained expression of homeobox D10 inhibits angiogenesis.

Authors:  Connie Myers; Aubri Charboneau; Irene Cheung; Douglas Hanks; Nancy Boudreau
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Development of a solid-phase assay for analysis of matrix metalloproteinase activity.

Authors:  Janelle L Lauer-Fields; Hideaki Nagase; Gregg B Fields
Journal:  J Biomol Tech       Date:  2004-12

Review 4.  Liver repopulation and carcinogenesis: two sides of the same coin?

Authors:  Fabio Marongiu; Silvia Doratiotto; Stefania Montisci; Paolo Pani; Ezio Laconi
Journal:  Am J Pathol       Date:  2008-03-05       Impact factor: 4.307

Review 5.  Matrix metalloproteinase collagenolysis in health and disease.

Authors:  Sabrina Amar; Lyndsay Smith; Gregg B Fields
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-26       Impact factor: 4.739

6.  Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells.

Authors:  Qiang Shen; Eugene S Lee; Robert L Pitts; Mack H Wu; Sarah Y Yuan
Journal:  Mol Cancer Res       Date:  2010-06-22       Impact factor: 5.852

7.  The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9.

Authors:  Sylvie Monferran; Jenny Paupert; Stéphanie Dauvillier; Bernard Salles; Catherine Muller
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

8.  Lipopolysaccharide upregulates uPA, MMP-2 and MMP-9 via ERK1/2 signaling in H9c2 cardiomyoblast cells.

Authors:  Yi-Chang Cheng; Li-Mien Chen; Mu-Hsin Chang; Wei-Kung Chen; Fuu-Jen Tsai; Chang-Hai Tsai; Tung-Yuan Lai; Wei-Wen Kuo; Chih-Yang Huang; Chung-Jung Liu
Journal:  Mol Cell Biochem       Date:  2009-01-28       Impact factor: 3.396

9.  Induction of tissue inhibitor of matrix metalloproteinase-2 by cholesterol depletion leads to the conversion of proMMP-2 into active MMP-2 in human dermal fibroblasts.

Authors:  Sangmin Kim; Jang-Hee Oh; Youngae Lee; Jeongyoon Lee; Kwang Hyun Cho; Jin Ho Chung
Journal:  Exp Mol Med       Date:  2010-01-31       Impact factor: 8.718

10.  Synthesis and evaluation of novel heterocyclic MMP inhibitors.

Authors:  Ryuji Hayashi; Xiaomin Jin; Gregory R Cook
Journal:  Bioorg Med Chem Lett       Date:  2007-10-17       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.